Synonyms: compound 8 [PMID: 29889526]
Compound class:
Synthetic organic
Comment: MMV024101 is one of the compounds with antimalarial activity from the Medicines for Malaria Venture (MMV) Pathogen Box.
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Guide to Malaria Pharmacology Comments |
MMV024101 was the starting point that lead to the discovery of the 2,8-Disubstituted-1,5-naphthyridine PI4K inhibitor compound 55 [PMID: 29889526] [1]. Potential Target/Mechanism Of Action: MMV024101 is an inhibitor of P. falciparum phosphatidylinositol-4-kinase beta (PfPI4Kβ) |